Format

Send to

Choose Destination
See comment in PubMed Commons below
Drug Discov Today. 2013 Jul;18(13-14):614-24. doi: 10.1016/j.drudis.2012.12.011. Epub 2012 Dec 29.

Challenges and opportunities for oncology biomarker discovery.

Author information

1
Knowledge Management, Merck Serono, 250 Frankfurterstrasse, Darmstadt 64293, Germany.

Abstract

Recent success of companion diagnostics along with the increasing regulatory pressure for better identification of the target population has created an unprecedented incentive for drug discovery companies to invest in novel strategies for biomarker discovery. In parallel with the rapid advancement and clinical adoption of high-throughput technologies, a number of knowledge management and systems biology approaches have been developed to analyze an ever increasing collection of OMICs data. This review discusses current biomarker discovery technologies highlighting challenges and opportunities of knowledge capturing and presenting a perspective of the future integrative modeling approaches as an emerging trend in biomarker prediction.

PMID:
23280501
DOI:
10.1016/j.drudis.2012.12.011
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center